United States · Bill · HR
H.R. 2507 (102nd)
Cancer Registries Amendment Act
Introduced
3 June 1991
Last action
24 June 1992 · Vote
Status
Message on House action received in Senate.
Sponsors
Rep. Waxman, Henry A. [D-CA-24]
Subjects
Healthcare, Environment, Taxation, Education
Source updated
21 April 2025
Healthcare · Environment · Taxation · Education
Summary
National Institutes of Health Revitalization Amendments of 1991 - Title I: General Provisions Regarding Title IV of Public Health Service Act - Subtitle A: Research Freedom - Part I: Review of Proposals for Biomedical and Behavioral Research - Amends the Public Health Service Act to require review and approval, by an Institutional Review Board, a peer review group, or other entity, before the Secretary of Health and Human Services may approve research or fund applications. Prohibits the Secretary from withholding funding, on ethical grounds, from research which has been so approved unless an ethics advisory board recommends withholding. Part II: Research on Transplantation of Fetal Tissue - Allows the Secretary to conduct or support research on the transplantation of human fetal tissue for therapeutic purposes, regardless of whether the tissue is obtained from a spontaneous abortion, an induced abortion, or a stillbirth, in accordance with State and local law. Establishes criminal penalties for knowingly acquiring, receiving, or otherwise transferring any human fetal tissue for valuable consideration. Excludes from the term "valuable consideration" reasonable payments associated with the transportation, implantation, processing, preservation, quality control, or storage of human fetal tissue. Prohibits any official of the executive branch from imposing a policy that prohibits the Department of Health and Human Services from conducting or supporting any research on the transplantation of human fetal tissue for therapeutic purposes. Prohibits the Secretary from withholding funds for research which meets requirements of this subtitle. Deems a specified report of the Human Fetal Tissue Transplantation Research Panel to: (1) be issued by an ethics advisory board under provisions of this subtitle; and (2) find that there are no ethical grounds for withholding funds for research on transplantation of human fetal tissue for therapeutic purposes. Part III: Technical and Conforming Amendments - Removes provisions requiring a study of the nature, advisability, and biomedical and ethical implications of exercising any waiver of a specified risk standard relating to fetal research. Subtitle B: Clinical Research Equity Regarding Women and Minorities - Part I: Women and Minorities as Subjects in Clinical Research - Requires the Director of the National Institutes of Health (NIH) and the Administrator of the Alcohol, Drug Abuse, and Mental Health Administration (ADAMHA) in conducting and supporting research, to ensure that: (1) women and minorities are included as subjects in each project; and (2) research is conducted so as to provide for a valid analysis of whether the variables being tested affect women or minorities differently than other research subjects. Requires technical and scientific peer review to include an evaluation of compliance with these requirements. Part II: Offices of Research on Women's Health - Establishes within each of the Office of the Director of NIH and the Office of the ADAMHA Administrator an Office of Research on Women's Health to identify projects of women's health (and, for ADAMHA, mental health) research and promote sufficient resource allocation for the conduct or support of the projects by NIH and ADAMHA. Requires the Directors of each Office to establish a Coordinating Committee on Research on Women's Health and an Advisory Committee on Research on Women's Health. Includes in the Coordinating Committee's duties determining the extent women are represented among senior physicians and scientists of NIH and ADAMHA and among physicians and scientists conducting research with NIH or ADAMHA funding and carrying out activities to increase such representation. Requires the Director of NIH to: (1) establish a single data system regarding research on women's health conducted or supported by NIH or ADAMHA; and (2) establish and operate a program to provide information on research and prevention activities of NIH and ADAMHA relating to research on women's health (and, for ADAMHA, mental health) and gender differences. Mandates a biennial report by each Director with specified contents, including analyzing the professional status of women physicians and scientists at NIH and ADAMHA and identifying advancement barriers. Directs the Secretary: (1) through the Directors of the Offices of Research on Women's Health, to contract for a study of how research on women's health can be facilitated by the NIH Director and the ADAMHA Administrator; and (2) to request the Institute of Medicine of the National Academy of Sciences to enter into the contract. Subtitle C: Scientific Integrity - Amends provisions relating to scientific fraud or scientific misconduct to establish within the Office of the Director of NIH the Office on Scientific Integrity. Provides for termination and recovery of financial assistance, provided for certain biomedical or behavioral research, if there is retaliation against a scientific misconduct whistleblower. Prohibits grants to or cooperative agreements or contracts with entities that fail to follow procedures to prevent or respond to such retaliation. Directs the Secretary, with regard to any entity receiving assistance for research to evaluate the safety or effectiveness of a drug, medical device, or treatment, to establish criteria for preventing or responding to any financial interests which will or may create a conflict of interest. Requires the criteria to be uniformly applicable to each entity. Allows individual variation in implementation. Prohibits allowing each entity to develop individual criteria. Allows the Secretary, where such a conflict of interest exists, to take certain actions, including disapproving an application, terminating assistance, and recovering assistance obligated while the conflict exists. Directs the Secretary to require the entity to disclose the conflict in each public presentation of the research results. Prohibits the Secretary, in fiscal years after regulations establishing the criteria are issued, from making a grant, cooperative agreement, or contract for biomedical or behavioral research unless the entity seeking assistance agrees to be subject to the regulations. Mandates a study by the Comptroller General on the extent to which the activities of the Director of the Office of Scientific Integrity have been effective in investigating and preventing scientific fraud and other misconduct. Directs the Secretary, through the National Library of medicine, to develop guidelines for use by scientific and medical journals to protect against publication of manuscripts involving scientific misconduct. Subtitle D: Indirect Costs - Allows the Secretary, in providing financial assistance through NIH for a research project, to authorize an entity to make expenditures from the assistance for administrative and nonadministrative indirect costs. Limits indirect cost expenditures to a percentage of direct costs. Requires a separate approval for certain building and equipment expenditures. Requires the NIH Director to establish a program of supporting biomedical or behavioral research projects whose principal researchers have not previously been principal researchers in such projects supported by the Director. Title II: Protection of Health Facilities - Prohibits stealing or otherwise converting personal property or damaging real property of a health facility assisted under the Public Health Service Act, or deterring, through physical restraint, any individual from entering or exiting the facility. Includes in the prohibitions various acts interfering with the use of animals for research. Provides for fines, imprisonment, restitution, and private civil actions. Title III: National Institutes of Health in General - Directs the Secretary to establish in the Office of the Director of NIH the Advisory Committee on Health Sciences to periodically review the missions of each of the agencies of NIH for the purpose of advising the NIH Director, the Secretary, and the Congress on any modifications in the organizational structure of NIH. Requires the approval of the Committee in order for the Secretary to establish, reorganize, or abolish a national research institute. Mandates preparation and implementation of a plan, regarding biomedical research and experimentation conducted or supported by NIH, for methods that: (1) do not require the use of animals; (2) reduce the number of animals used; and (3) produce less pain and distress in animals. Requires measures to encourage acceptance and training in such methods. Establishes the Interagency Coordinating Committee on the Use of Animals in Research. Repeals similar provisions, relating to a plan on animal research and a coordinating committee, of the Health Research Extension Act of 1985. Removes provisions of the Public Health Service Act allowing members of advisory councils to serve after the expiration of their terms until successors have taken office. Title IV: General Provisions Respecting National Research Institutes - Requires that the Secretary, through the director of each of the national research institutes, receive directly all funds appropriated for the institute. Removes provisions allowing the Director of the National Cancer Institute (NCI) to directly receive NCI funds. Excludes peer review groups under specified provisions from the application of the Federal Advisory Committee Act. Requires the Director of NIH to: (1) carry out a program to expand and intensify research on osteoporosis, Paget's disease, and related bone disorders in addition to research authorized under other Federal law; (2) establish the Advisory Board on Osteoporosis, Paget's Disease, and Related Bone Disorders; and (3) enter into a grant, cooperative agreement, or contract to establish an information clearinghouse on osteoporosis and related bone disorders. Authorizes appropriations. Title V: National Cancer Institute - Authorizes appropriations for the National Cancer Institute. Title VI: National Heart, Lung, and Blood Institute - Authorizes the National Heart, Lung, and Blood Institute (NHLBI) to conduct programs of training and education, including continuing education and laboratory and clinical research training. Title VII: National Institute on Aging - Transfers provisions of the Health Research Extension Act of 1985 establishing an Alzheimer's disease registry to provisions of the Public Health Service Act relating to the National Institute on Aging (NIA). Transfers provisions of the Health Research Extension Act of 1985 establishing an Alzheimer's disease registry to provisions of the Public Health Service Act relating to the National Institute on Aging (NIA). Authorizes appropriations for the NIA. Title VIII: National Institute of Allergy and Infectious Diseases - Authorizes the Director of the National Institute of Allergy and Infectious Diseases to make grants or enter into contracts for the development and operation of centers to conduct basic and clinical research on chronic fatigue syndrome. Title IX: National Institute of Child Health and Human Development - Subtitle A: Research Centers With Respect to Contraception and Research Centers With Respect to Infertility - Requires the Director of the NICHHD to make grants and enter into contracts for the development and operation of centers to conduct contraception research and centers to conduct infertility research. Directs the Secretary to establish a program of educational loan repayments for health professionals who agree to conduct research on contraception or on infertility. Subtitle B: Program Regarding Obstetrics and Gynecology - Requires the Director of the NICHHD to establish and maintain an intramural laboratory and clinical research program in obstetrics and gynecology. Subtitle C: Child Health Research Centers - Requires the Director of the NICHHD to develop and support centers for conducting research on child health, giving priority to clinical applications of basic research findings. Title X: National Institute of Neurological Disorders and Stroke - Requires the Director of the National Institute of Neurological Disorders and Stroke to conduct and support research on multiple sclerosis. Title XI: National Institute of Environmental Health Sciences - Establishes in the National Institute of Environmental Health Science the Applied Toxicological Research and Testing Program. Title XII: National Library of Medicine - Subtitle A: General Provisions - Adds to the list of functions of the National Library of Medicine (NLM) that of publicizing NLM products and services and promoting the use of computers and telecommunications by health professionals. Authorizes appropriations to carry out provisions relating to: (1) the NLM and to other medical libraries, including regional medical libraries; (2) training in medical library sciences; and (3) biomedical publications. Subtitle B: Financial Assistance - Directs the Secretary to make grants for research on, and development and demonstration of, new education technologies. Subtitle C: National Center for Biotechnology Information - Authorizes appropriations for the National Center for Biotechnology Information. Subtitle D: National Information Center on Health Services Research and Health Care Technology - Establishes in the NLM the National Information Center on Health Services Research and Health Care Technology. Removes similar provisions from provisions relating to the Agency for Health Care Policy and Research. Title XIII: Other Agencies of National Institutes of Health - Subtitle A: Division of Research Resources - Redesignates the Division of Research Resources as the National Center for Research Resources. Authorizes the Director of NIH to reserve up to a specified sum to improve regional centers for research on primates. Subtitle B: National Center for Human Genome Research - Adds the National Center for Human Genome Research to the list of agencies of NIH. Declares that the purpose of the Center is to characterize the structure and function of the human genome, including the mapping and sequencing of individual genes. Requires the Director of the Center to make available a minimum percentage of funds for carrying out provisions relating to ethical issues associated with the genome project. Title XIV: Awards and Training - Subtitle A: National Research Service Awards - Directs the Secretary to make grants for comprehensive programs to recruit women and individuals from disadvantaged backgrounds into fields of biomedical or behavioral research and to provide research training to women and such individuals. Authorizes appropriations for payments and grants under National Research Service Awards. Subtitle B: Acquired Immune Deficiency Syndrome - Allows the Secretary, under a loan repayment program for research with respect to acquired immune deficiency syndrome (AIDS) established by existing provisions, to enter into a repayment agreement with a health professional who agrees to conduct AIDS research at NIH for at least three years, provided other conditions are met. Authorizes appropriations. Authorizes the Commissioner of Food and Drugs to carry out for the Food and Drug Administration a similar loan repayment program with respect to the review of applications concerning AIDS that are submitted to the Commissioner. Subtitle C: Scholarship and Loan Repayment Programs Regarding Professional Skills Needed by Certain Agencies - Directs the Secretary, through the Director of NIH and the Administrator of ADAMHA, to establish programs of scholarships for undergraduate education for individuals from disadvantaged backgrounds who are underrepresented in professions needed by NIH and ADAMHA in return for the scholarship recipients agreeing to serve as an employee of NIH or ADAMHA for a prescribed period. Requires that the Director and the Administrator: (1) carry out activities to facilitate the interest of the individuals in pursuing careers as employees of NIH and ADAMHA; and (2) approve the academic program of each individual. Directs the Secretary, through the Director and the Administrator, to establish programs of repaying educational loans for individuals from disadvantaged backgrounds who have a substantial amount of education loans relative to income in return for the repayment recipients agreeing to conduct clinical research as employees of NIH or ADAMHA. Limits the NIH scholarship and loan programs to an aggregate of 40 contracts and the ADAMHA programs to an aggregate of 10 contracts. Title XV: Research with Respect to Acquired Immune Deficiency Syndrome - Modifies the duties of the AIDS Clinical Research Review Committee, including requiring the Committee to give advice to other agencies of NIH as well as to the National Institute of Allergy and Infectious Diseases (NIAID). States that the requirement that the clinical evaluation units at the National Cancer Institute and NIAID conduct evaluations of treatments for acquired immune deficiency syndrome (AIDS) includes evaluations of treatments for opportunistic cancers and infectious diseases. Authorizes appropriations for model protocols for the clinical care of individuals infected with the etiologic agent for AIDS. Requires the Director of NIH to develop and implement a comprehensive plan for the conduct and support of AIDS research by NIH agencies. Title XVI: Miscellaneous Provisions - Directs the Secretary to report to specified congressional committees on the appropriateness and impact of NIH assuming responsibility for all Federal research, development, testing, and evaluation functions relating to the medical aspects of biological agents in the development of defenses against biological warfare. Renames the Senior Biomedical Research Service as the Silvio Conte Senior Biomedical Research Service. Increases the maximum number of members of the Service. Declares that the authority regarding the number of members in the Service is in addition to the numbers authorized for the Regular Corps, the Reserve Corps, and the Senior Executive Service. Renames the AIDS clinical Research Review Committee as the AIDS Research Advisory Committee. Title XVII: Effective Date - Sets forth the effective date of this Act.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
3 June 1991
Committee
For Previous Action See H.R.1532.
Source: Committee
3 June 1991
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
3 June 1991
Introduced
Introduced in House
Source: IntroReferral
3 June 1991
Introduced
Introduced in House
Source: IntroReferral
4 June 1991
Committee
Committee Consideration and Mark-up Session Held.
Source: Committee
4 June 1991
Reported
Ordered to be Reported (Amended).
Source: Committee
26 June 1991
Passed
Mr. Waxman asked unanimous consent that the Committee on Energy and Commerce have until 6:00 p.m. on June 28 to file a report on H.R. 2507. Agreed to without objection.
Source: Committee
28 June 1991
Calendars
Placed on the Union Calendar, Calendar No. 92.
Source: Calendars
28 June 1991
Reported
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 102-136. Filed late, pursuant to previous special order.
Source: Committee
28 June 1991
Reported
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 102-136. Filed late, pursuant to previous special order.
Source: Committee
24 July 1991
Reported
Rules Committee Resolution H. Res. 202 Reported to House. Rule provides for consideration of H.R. 2507 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit with or without instructions. It shall be in order to consider the amendment in the nature of a substitute now printed in the bill as an original bill for the purpose of amendment. Measure will be considered read. Specified amendments are in order. No amendment shall be in order except the amendments printed in the report accompanying this resolution. Said amendments shall be considered in the order and manner specified, considered as having been read when offered, debatable for the period of time specified and shall not be subject to amendment except as specified in the report.
Source: Floor
25 July 1991
Passed
Motion to reconsider laid on the table Agreed to without objection.
Source: Floor
25 July 1991
Vote
On passage Passed by recorded vote: 274 - 144 (Roll no. 229).
Source: Floor
25 July 1991
Vote
Passed/agreed to in House: On passage Passed by recorded vote: 274 - 144 (Roll no. 229).
Source: Floor
25 July 1991
Passed
The House adopted the amendment in the nature of a substitute as agreed to by the Committee of the Whole House on the state of the Union.
Source: Floor
25 July 1991
Floor
The previous question was ordered pursuant to the rule.
Source: Floor
25 July 1991
Floor
The Speaker designated the Honorable Leon E. Panetta to act as Chairman of the Committee.
Source: Floor
25 July 1991
Floor
House resolved itself into the Committee of the Whole House on the state of the Union pursuant to H. Res. 202 and Rule XXIII.
Source: Floor
25 July 1991
Floor
Considered under the provisions of rule H. Res. 202.
Source: Floor
25 July 1991
Passed
Rule H. Res. 202 passed House.
Source: Floor
25 July 1991
Floor
The House rose from the Committee of the Whole House on the state of the Union to report H.R. 2507.
Source: Floor
25 July 1991
Floor
Rule provides for consideration of H.R. 2507 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit with or without instructions. It shall be in order to consider the amendment in the nature of a substitute now printed in the bill as an original bill for the purpose of amendment. Measure will be considered read. Specified amendments are in order. No amendment shall be in order except the amendments printed in the report accompanying this resolution. Said amendments shall be considered in the order and manner specified, considered as having been read when offered, debatable for the period of time specified and shall not be subject to amendment except as specified in the report.
Source: Floor
29 July 1991
Introduced
Received in the Senate and read twice and referred to the Committee on Labor and Human Resources.
Source: IntroReferral
5 February 1992
Reported
Committee on Labor and Human Resources. Ordered to be reported with an amendment in the nature of a substitute favorably.
Source: Committee
13 March 1992
Calendars
Placed on Senate Legislative Calendar under General Orders. Calendar No. 422.
Source: Calendars
13 March 1992
Reported
Committee on Labor and Human Resources. Reported to Senate by Senator Kennedy with an amendment in the nature of a substitute. With written report No. 102-263. Additional views filed.
Source: Committee
13 March 1992
Reported
Committee on Labor and Human Resources. Reported to Senate by Senator Kennedy with an amendment in the nature of a substitute. With written report No. 102-263. Additional views filed.
Source: Committee
26 March 1992
Floor
Motion to proceed to consideration of measure made in Senate.
Source: Floor
31 March 1992
Vote
Cloture on the motion to proceed invoked in Senate by Yea-Nay Vote. 98-2. Record Vote No: 60.
Source: Floor
2 April 1992
Vote
Passed Senate with an amendment by Yea-Nay Vote. 87-10. Record Vote No: 66.
Source: Floor
2 April 1992
Vote
Passed/agreed to in Senate: Passed Senate with an amendment by Yea-Nay Vote. 87-10. Record Vote No: 66.
Source: Floor
7 April 1992
Floor
Message on Senate action sent to the House.
Source: Floor
10 April 1992
Passed
On motion that the House disagree to the Senate amendment, and request a conference Agreed to without objection.
Source: ResolvingDifferences
10 April 1992
Floor
Message on House action received in Senate and held at desk: House requests a conference and disagrees to the amendment of the Senate.
Source: Floor
10 April 1992
Floor
By unanimous consent, the Speaker reserved the right to appoint additional conferees.
Source: Floor
10 April 1992
ResolvingDifferences
The Speaker appointed conferees - from the Committee on Energy and Commerce for consideration of the House bill, and the Senate amendment, and modifications committed to conference: Dingell, Waxman, Wyden, Lent, and Bliley.
Source: ResolvingDifferences
10 April 1992
Passed
Motion to reconsider laid on the table Agreed to without objection.
Source: ResolvingDifferences
10 April 1992
ResolvingDifferences
Mr. Waxman asked unanimous consent that the House disagree to the Senate amendment, and request a conference.
Source: ResolvingDifferences
6 May 1992
ResolvingDifferences
Senate insists on its amendment, agrees to request for a conference, appoints conferees Kennedy; Harkin; Adams; Hatch; Durenberger.
Source: ResolvingDifferences
7 May 1992
Floor
Message on Senate action sent to the House.
Source: Floor
18 May 1992
Passed
Conferees agreed to file conference report.
Source: ResolvingDifferences
18 May 1992
Passed
Conference committee actions: Conferees agreed to file conference report.
Source: ResolvingDifferences
18 May 1992
ResolvingDifferences
Conference report H. Rept. 102-525 filed.
Source: ResolvingDifferences
18 May 1992
ResolvingDifferences
Conference report filed: Conference report H. Rept. 102-525 filed.
Source: ResolvingDifferences
19 May 1992
ResolvingDifferences
Conference papers: Senate report and managers' statement held at the desk in Senate.
Source: ResolvingDifferences
21 May 1992
Reported
Rules Committee Resolution H. Res. 466 Reported to House. Rule provides for consideration of the conference report to H.R. 2507. All points of order against the conference report and against its consideration are waived. Debate on the conference report shall continue for not to exceed one hour, equally divided and controlled.
Source: Floor
28 May 1992
Vote
On agreeing to the conference report Agreed to by the Yeas and Nays: 260 - 148 (Roll No. 147).
Source: ResolvingDifferences
28 May 1992
Passed
Motions to reconsider laid on the table Agreed to without objection.
Source: ResolvingDifferences
28 May 1992
Vote
Conference report agreed to in House: On agreeing to the conference report Agreed to by the Yeas and Nays: 260 - 148 (Roll No. 147).
Source: ResolvingDifferences
28 May 1992
ResolvingDifferences
The previous question was ordered without objection.
Source: ResolvingDifferences
28 May 1992
Floor
DEBATE - Pursuant to the provisions of H. Res. 466, the House proceeded with one hour of debate on the conference report.
Source: Floor
28 May 1992
ResolvingDifferences
Mr. Waxman brought up conference report H. Rept. 102-525 for consideration under the provisions of H. Res. 466.
Source: ResolvingDifferences
28 May 1992
Passed
Rule H. Res. 466 passed House.
Source: Floor
2 June 1992
ResolvingDifferences
Conference papers: message on House action held at the desk in Senate.
Source: ResolvingDifferences
4 June 1992
ResolvingDifferences
Conference report considered in Senate.
Source: ResolvingDifferences
4 June 1992
Vote
Conference report agreed to in Senate: Senate agreed to conference report by Yea-Nay Vote. 85-12. Record Vote No: 115.
Source: ResolvingDifferences
10 June 1992
Floor
Message on Senate action sent to the House.
Source: Floor
17 June 1992
Floor
Presented to President.
Source: Floor
17 June 1992
President
Presented to President.
Source: President
23 June 1992
President
Vetoed by President.
Source: President
23 June 1992
President
Vetoed by President.
Source: President
24 June 1992
Floor
DEBATE - The Speaker ordered that the veto message, together with the accompanying bill, be printed and spread upon the pages of the Journal of the House. The House then proceeded with one hour of debate on the question of passage, the objections of the President to the contrary notwithstanding.
Source: Floor
24 June 1992
Veto
The Chair laid before the House the veto message from the President.
Source: Veto
24 June 1992
Floor
Message on House action received in Senate.
Source: Floor
24 June 1992
Referred
The bill and the accompanying veto message was referred to the Committee on Energy and Commerce without objection.
Source: Veto
24 June 1992
Vote
On passage, the objections of the President to the contrary notwithstanding Failed by the Yeas and Nays (2/3 required): 271 - 156 (Roll No. 222).
Source: Veto
24 June 1992
Vote
Failed of passage in House over veto: On passage, the objections of the President to the contrary notwithstanding Failed by the Yeas and Nays (2/3 required): 271 - 156 (Roll No. 222).
Source: Veto
Votes
4 June 1992 · Conference Report Agreed to · On the Conference Report H.R. 2507 · Conference Report Agreed to · Official source
Yes 85 · No 12 · Abstain — · Absent/not voting 3
- Sen. Cranston, Alan [D-CA]Yea
- Sen. Dixon, Alan J. [D-IL]Yea
- Sen. Simpson, Alan K. [R-WY]Yea
- Sen. Gore, Albert, Jr. [D-TN]Yea
- Sen. D'Amato, Alfonse [R-NY]Nay
- Sen. Specter, Arlen [R-PA]Yea
- Sen. Mikulski, Barbara A. [D-MD]Yea
- Sen. Bradley, Bill [D-NJ]Yea
Showing the first 8 recorded positions. Vote totals above are complete.
2 April 1992 · Bill Passed · On Passage of the Bill H.R. 2507 · Bill Passed · Official source
Yes 87 · No 10 · Abstain — · Absent/not voting 3
- Sen. Cranston, Alan [D-CA]Yea
- Sen. Dixon, Alan J. [D-IL]Not Voting
- Sen. Simpson, Alan K. [R-WY]Yea
- Sen. Gore, Albert, Jr. [D-TN]Yea
- Sen. D'Amato, Alfonse [R-NY]Yea
- Sen. Specter, Arlen [R-PA]Yea
- Sen. Mikulski, Barbara A. [D-MD]Yea
- Sen. Bradley, Bill [D-NJ]Yea
Showing the first 8 recorded positions. Vote totals above are complete.
31 March 1992 · Cloture Motion Agreed to · On the Cloture Motion H.R. 2507 · Cloture Motion Agreed to · Official source
Yes 98 · No 2 · Abstain — · Absent/not voting 0
- Sen. Cranston, Alan [D-CA]Yea
- Sen. Dixon, Alan J. [D-IL]Yea
- Sen. Simpson, Alan K. [R-WY]Yea
- Sen. Gore, Albert, Jr. [D-TN]Yea
- Sen. D'Amato, Alfonse [R-NY]Yea
- Sen. Specter, Arlen [R-PA]Yea
- Sen. Mikulski, Barbara A. [D-MD]Yea
- Sen. Bradley, Bill [D-NJ]Yea
Showing the first 8 recorded positions. Vote totals above are complete.
Versions
- Engrossed Amendment Senate · undated · Official file
- Engrossed in House · undated · Official file
- Enrolled Bill · undated · Official file
- Introduced in House · undated · Official file
- Referred in Senate · undated · Official file
- Reported in House · undated · Official file
- Reported to Senate · undated · Official file
Documents
11 official files
Reported to Senate (text)
Reported to Senate (text)
Reported to Senate · EN
Reported in House (text)
Reported in House · EN
Referred in Senate (text)
Referred in Senate · EN
Introduced in House (text)
Introduced in House · EN
Enrolled Bill (text)
Enrolled Bill · EN
Engrossed in House (text)
Engrossed in House · EN
Engrossed Amendment Senate (text)
Engrossed Amendment Senate · EN
Conference report filed in House
summary · EN · 18 May 1992
Reported to Senate with amendment(s)
summary · EN · 13 March 1992
Passed House amended
summary · EN · 25 July 1991
Introduced in House
summary · EN · 3 June 1991
Sponsors
- Rep. Waxman, Henry A. [D-CA-24] · D · Sponsor
- · sshr00 · Standing
- · hsif00 · Standing
Related records
- related to → National Institutes of Health Revitalization Amendments of 1991
- related to → National Institutes of Health Revitalization Amendments of 1991
- related to → Providing for the consideration of the bill (H.R. 2507) to amend the Public Health Service Act to revise and extend the programs of the National Institutes of Health, and for other purposes.
- related to → Waiving all points of order against the conference report on the bill (H.R. 2507) to amend the Public Health Service Act to revise and extend the programs of the National Institutes of Health, and for other purposes.
- related to ← National Institutes of Health Revitalization Amendments of 1992
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/102nd-congress/house-bill/2507
- Open data entity: https://api.congress.gov/v3/bill/102/hr/2507
- us · 102-hr-2507 · source updated 21 April 2025